Researcher’s work on E. coli makes Discover magazine’s top 100 list
EAST LANSING, Mich. â€" A Michigan State University researcher's vaccine development for a strain of E. coli that kills millions of children each year in the developing world has been named one of 2009's top stories by Discover magazine.
(Media-Newswire.com) - EAST LANSING, Mich. — A Michigan State University researcher's vaccine development for a strain of E. coli that kills millions of children each year in the developing world has been named one of 2009's top stories by Discover magazine.
A. Mahdi Saeed, professor of epidemiology and infectious disease in MSU's colleges of Veterinary Medicine and Human Medicine, has studied enterotoxigenic E. Coli - which is responsible for 60 percent to 70 percent of all E. coli diarrheal disease - for 25 years. The disease also causes health problems for U.S. troops serving overseas and is responsible for what is commonly called traveler's diarrhea.
As part of its year-end issue on newsstands now, Discover magazine counted down 100 of the year's top stories; Saeed's work on the vaccine came in at No. 36. Other featured stories include one on tropical heat speeding up evolution and another on the Hubble Space Telescope's new abilities.
"A working vaccine has the potential to save millions of lives," said Saeed, who hopes human clinical trials will begin in early 2010. "This strain of E. coli has a huge impact on humanity."
Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.
Related Content
Published by:
N/A
Release Date
This story was released on 2009-12-23. Please make sure to visit the official company or organization web site to learn more about the original release date. See our disclaimer for additional information.